A real world study of efficacy and safety with apatinib therapy in advanced neuroendocrine carcinoma patients.

2018 
e14567Background: There is no standard therapeutic method for advanced neuroendocrine carcinoma patients after second line systemic therapy. It’s need novel effective therapies for these patients. ...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []